Abstract

BackgroundFactors driving inter-individual differences in immune responses upon different types of prenatal malaria exposure (PME) and subsequent risk of malaria in infancy remain poorly understood. In this study, we examined the impact of four types of PME (i.e., maternal peripheral infection and placental acute, chronic, and past infections) on both spontaneous and toll-like receptors (TLRs)-mediated cytokine production in cord blood and how these innate immune responses modulate the risk of malaria during the first year of life.MethodsWe conducted a birth cohort study of 313 mother-child pairs nested within the COSMIC clinical trial (NCT01941264), which was assessing malaria preventive interventions during pregnancy in Burkina Faso. Malaria infections during pregnancy and infants’ clinical malaria episodes detected during the first year of life were recorded. Supernatant concentrations of 30 cytokines, chemokines, and growth factors induced by stimulation of cord blood with agonists of TLRs 3, 7/8, and 9 were measured by quantitative suspension array technology. Crude concentrations and ratios of TLR-mediated cytokine responses relative to background control were analyzed.ResultsSpontaneous production of innate immune biomarkers was significantly reduced in cord blood of infants exposed to malaria, with variation among PME groups, as compared to those from the non-exposed control group. However, following TLR7/8 stimulation, which showed higher induction of cytokines/chemokines/growth factors than TLRs 3 and 9, cord blood cells of infants with evidence of past placental malaria were hyper-responsive in comparison to those of infants not-exposed. In addition, certain biomarkers, which levels were significantly modified depending on the PME category, were independent predictors of either malaria risk (GM-CSF TLR7/8 crude) or protection (IL-12 TLR7/8 ratio and IP-10 TLR3 crude, IL-1RA TLR7/8 ratio) during the first year of life.ConclusionsThese findings indicate that past placental malaria has a profound effect on fetal immune system and that the differential alterations of innate immune responses by PME categories might drive heterogeneity between individuals to clinical malaria susceptibility during the first year of life.

Highlights

  • Factors driving inter-individual differences in immune responses upon different types of prenatal malaria exposure (PME) and subsequent risk of malaria in infancy remain poorly understood

  • We assessed the effect of different types of prenatal malaria exposure (PME) on endosomal toll-like receptors (TLRs)-mediated cytokine responses in cord blood samples collected at birth, and we investigated the subsequent risk of malaria during the first year of life in a highly seasonal malaria endemic area of Burkina Faso

  • The main effect was observed in responses to TLR7/8 stimulation (Additional file 2: Figure S5), being past placental malaria (PM) more frequently associated with a significantly higher production of cytokine levels (i.e., IFN-α, IL-2, macrophage inflammatory protein (MIP)-1α, RANTES, fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF)) compared with the non-exposed control group (ANOVA, P < 0.05)

Read more

Summary

Introduction

Factors driving inter-individual differences in immune responses upon different types of prenatal malaria exposure (PME) and subsequent risk of malaria in infancy remain poorly understood. Despite the widespread implementation of Intermittent Preventive Treatment with sulfadoxine-pyrimethamine (IPTp-SP) to prevent malaria during pregnancy, infants in endemic countries are often born to mothers with placental malaria (PM). Cord blood mononuclear cells of neonates born to mothers with PM can respond to plasmodial asexual blood stage antigens, impacting on immune response to Plasmodium falciparum infection during infancy [9,10,11,12,13,14,15] This prenatal exposure to malariainfected erythrocytes or their soluble products can lead to fetal immune priming to malaria blood stage antigens or to fetal immune tolerance in some infants [11, 16,17,18,19,20]. Factors that lead to this inter-individual difference in immune responses to malaria antigens upon prenatal exposure are unknown

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call